Repligen | Kortsiktig Gjeld

Current Liabilities Endring Dato
Agilent USD 1.96B 341M 2024-04
Align Technology USD 2.02B 43.57M 2024-03
Bio Techne USD 149.82M 14.59M 2024-03
BioMarin Pharmaceutical USD 1.09B 89.12M 2024-03
Bristol-Myers Squibb USD 25.82B 2.36B 2024-03
Bruker USD 1.18B 8.5M 2024-03
Catalent USD 1.01B 29M 2024-03
Charles River Laboratories USD 954.81M 100.27M 2024-03
Danaher USD 7.78B 496M 2024-03
Dentsply International USD 1.33B 95M 2024-03
Exact Sciences USD 685.11M 170.41M 2024-03
General Electric USD 51.09B 210M 2024-03
Henry Schein USD 2.33B 349M 2024-03
Illumina USD 1.47B 96M 2024-03
IQVIA Holdings USD 6.45B 43M 2024-03
Mettler Toledo International USD 1.13B 49.15M 2024-03
Myriad Genetics USD 146.1M 9.8M 2024-03
Patterson Companies USD 1.28B 135.17M 2024-01
Pfizer USD 40.5B 9.36B 2024-03
Repligen USD 178.32M 185.05M 2024-03
Revvity USD 1.37B 76.24M 2024-03
Standard Biotools USD 121.55M 12.23M 2024-03
Thermo Fisher Scientific USD 13.94B 75M 2024-03
Waters USD 789.58M 44.55M 2023-12
West Pharmaceutical Services USD 648.4M 114.9M 2024-03



Repligen Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.